Cargando…

Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes

BACKGROUND: In Switzerland and other developed countries, the number of tuberculosis (TB) cases has been decreasing for decades, but HIV-infected patients and migrants remain risk groups. The aim of this study was to compare characteristics of TB in HIV-negative and HIV-infected patients diagnosed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenner, Lukas, Gagneux, Sebastien, Janssens, Jean-Paul, Fehr, Jan, Cavassini, Matthias, Hoffmann, Matthias, Bernasconi, Enos, Schrenzel, Jacques, Bodmer, Thomas, Böttger, Erik C., Helbling, Peter, Egger, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316631/
https://www.ncbi.nlm.nih.gov/pubmed/22479556
http://dx.doi.org/10.1371/journal.pone.0034186
_version_ 1782228450393718784
author Fenner, Lukas
Gagneux, Sebastien
Janssens, Jean-Paul
Fehr, Jan
Cavassini, Matthias
Hoffmann, Matthias
Bernasconi, Enos
Schrenzel, Jacques
Bodmer, Thomas
Böttger, Erik C.
Helbling, Peter
Egger, Matthias
author_facet Fenner, Lukas
Gagneux, Sebastien
Janssens, Jean-Paul
Fehr, Jan
Cavassini, Matthias
Hoffmann, Matthias
Bernasconi, Enos
Schrenzel, Jacques
Bodmer, Thomas
Böttger, Erik C.
Helbling, Peter
Egger, Matthias
author_sort Fenner, Lukas
collection PubMed
description BACKGROUND: In Switzerland and other developed countries, the number of tuberculosis (TB) cases has been decreasing for decades, but HIV-infected patients and migrants remain risk groups. The aim of this study was to compare characteristics of TB in HIV-negative and HIV-infected patients diagnosed in Switzerland, and between coinfected patients enrolled and not enrolled in the national Swiss HIV Cohort Study (SHCS). METHODS AND FINDINGS: All patients diagnosed with culture-confirmed TB in the SHCS and a random sample of culture-confirmed cases reported to the national TB registry 2000–2008 were included. Outcomes were assessed in HIV-infected patients and considered successful in case of cure or treatment completion. Ninety-three SHCS patients and 288 patients selected randomly from 4221 registered patients were analyzed. The registry sample included 10 (3.5%) coinfected patients not enrolled in the SHCS: the estimated number of HIV-infected patients not enrolled in the SHCS but reported to the registry 2000–2008 was 146 (95% CI 122–173). Coinfected patients were more likely to be from sub-Saharan Africa (51.5% versus 15.8%, P<0.0001) and to present disseminated disease (23.9% vs. 3.4%, P<0.0001) than HIV-negative patients. Coinfected patients not enrolled in the SHCS were asylum seekers or migrant workers, with lower CD4 cell counts at TB diagnosis (median CD4 count 79 cells/µL compared to 149 cells/µL among SHCS patients, P = 0.07). There were 6 patients (60.0%) with successful outcomes compared to 82 (88.2%) patients in the SHCS (P = 0.023). CONCLUSIONS: The clinical presentation of coinfected patients differed from HIV-negative TB patients. The number of HIV-infected patients diagnosed with TB outside the SHCS is similar to the number diagnosed within the cohort but outcomes are poorer in patients not followed up in the national cohort. Special efforts are required to address the needs of this vulnerable population.
format Online
Article
Text
id pubmed-3316631
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33166312012-04-04 Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes Fenner, Lukas Gagneux, Sebastien Janssens, Jean-Paul Fehr, Jan Cavassini, Matthias Hoffmann, Matthias Bernasconi, Enos Schrenzel, Jacques Bodmer, Thomas Böttger, Erik C. Helbling, Peter Egger, Matthias PLoS One Research Article BACKGROUND: In Switzerland and other developed countries, the number of tuberculosis (TB) cases has been decreasing for decades, but HIV-infected patients and migrants remain risk groups. The aim of this study was to compare characteristics of TB in HIV-negative and HIV-infected patients diagnosed in Switzerland, and between coinfected patients enrolled and not enrolled in the national Swiss HIV Cohort Study (SHCS). METHODS AND FINDINGS: All patients diagnosed with culture-confirmed TB in the SHCS and a random sample of culture-confirmed cases reported to the national TB registry 2000–2008 were included. Outcomes were assessed in HIV-infected patients and considered successful in case of cure or treatment completion. Ninety-three SHCS patients and 288 patients selected randomly from 4221 registered patients were analyzed. The registry sample included 10 (3.5%) coinfected patients not enrolled in the SHCS: the estimated number of HIV-infected patients not enrolled in the SHCS but reported to the registry 2000–2008 was 146 (95% CI 122–173). Coinfected patients were more likely to be from sub-Saharan Africa (51.5% versus 15.8%, P<0.0001) and to present disseminated disease (23.9% vs. 3.4%, P<0.0001) than HIV-negative patients. Coinfected patients not enrolled in the SHCS were asylum seekers or migrant workers, with lower CD4 cell counts at TB diagnosis (median CD4 count 79 cells/µL compared to 149 cells/µL among SHCS patients, P = 0.07). There were 6 patients (60.0%) with successful outcomes compared to 82 (88.2%) patients in the SHCS (P = 0.023). CONCLUSIONS: The clinical presentation of coinfected patients differed from HIV-negative TB patients. The number of HIV-infected patients diagnosed with TB outside the SHCS is similar to the number diagnosed within the cohort but outcomes are poorer in patients not followed up in the national cohort. Special efforts are required to address the needs of this vulnerable population. Public Library of Science 2012-03-30 /pmc/articles/PMC3316631/ /pubmed/22479556 http://dx.doi.org/10.1371/journal.pone.0034186 Text en Fenner et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fenner, Lukas
Gagneux, Sebastien
Janssens, Jean-Paul
Fehr, Jan
Cavassini, Matthias
Hoffmann, Matthias
Bernasconi, Enos
Schrenzel, Jacques
Bodmer, Thomas
Böttger, Erik C.
Helbling, Peter
Egger, Matthias
Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes
title Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes
title_full Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes
title_fullStr Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes
title_full_unstemmed Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes
title_short Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes
title_sort tuberculosis in hiv-negative and hiv-infected patients in a low-incidence country: clinical characteristics and treatment outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316631/
https://www.ncbi.nlm.nih.gov/pubmed/22479556
http://dx.doi.org/10.1371/journal.pone.0034186
work_keys_str_mv AT fennerlukas tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT gagneuxsebastien tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT janssensjeanpaul tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT fehrjan tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT cavassinimatthias tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT hoffmannmatthias tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT bernasconienos tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT schrenzeljacques tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT bodmerthomas tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT bottgererikc tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT helblingpeter tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT eggermatthias tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes
AT tuberculosisinhivnegativeandhivinfectedpatientsinalowincidencecountryclinicalcharacteristicsandtreatmentoutcomes